Company Analysis

Odyssey Therapeutics, Inc. (ODTX)

Nasdaq: ODTX · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2021
Grade5.8
◀ Past 5.9● Present 6.5▶ Future 5.0
8 est.

Patents

US patents, PatentsView, from the USPTO

No patent on file prints this company’s names. A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in.

A subsidiary’s patents are counted only where the list of subsidiaries filed with its annual report has been read, and a patent sold to it after it was granted is not read. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. PatentsView at the USPTO

SI Assistanton ODTX · research, not advice